Cornelia Merzyn

发表

Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis.

M. Buttmann, P. Rieckmann, Cornelia Merzyn, 2004, Journal of neuroimmunology.

TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-β treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response

M. Buttmann, P. Rieckmann, Cornelia Merzyn, 2007, Journal of Neuroimmunology.

Interferon-β induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis

M. Buttmann, P. Rieckmann, Cornelia Merzyn, 2004, Journal of Neuroimmunology.